New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
07:10 EDTSPPISpectrum expects revenues, operating income to increase in 2013
News For SPPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2015
09:17 EDTSPPICourt lifts injunction on sales of generic copy of Spectrum's Fusilev
The U.S. Court of Appeals for the Federal Circuit yesterday issued an order that lifted a temporary injunction put in place March 6 that had blocked Novartis' (NVS) Sandoz unit from selling a generic version of Spectrum Pharmaceuticals' (SPPI) colorectal cancer treatment Fusilev. The appeals court ruled that Spectrum failed to meet the requirements for an injunction pending appeal.
09:00 EDTSPPISpectrum revenue under 'major threat' after ruling, says Roth Capital
Roth Capital says an appeals court ruling yesterday denying Spectrum's injunction motion aimed to block Sandoz's generic Fusilev launch represents a "major threat" to Spectrum's revenue stream. Roth expects erosion of the company's Fusilev sales once the generic is launched and maintained a Neutral rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use